Head and Neck TumorsHead and Neck TumorsОпухоли головы и шеи2222-14682411-4634Publishing House ABV Press94310.17650/2222-1468-2023-13-4-116-123REVIEWОБЗОРНАЯ СТАТЬЯThe importance in clinical practice of the signal lymph node biopsy in squamous cell carcinoma of the head and neckЗначимость в клинической практике биопсии сигнального лимфатического узла при плоскоклеточном раке кожи головы и шеиhttps://orcid.org/0000-0002-4496-6128GelfandI. M.ГельфандИ. М.
Russian Federation

Igor Mikhailovich Gelfand

115522; 24 Kashirskoye Shosse; Moscow

Игорь Михайлович Гельфанд

115522; Каширское шоссе, 24; Москва

igorgelf@yandex.ruhttps://orcid.org/0000-0002-9132-3416KropotovM. A.КропотовМ. А.
Russian Federation

115522; 24 Kashirskoye Shosse; Moscow

115522; Каширское шоссе, 24; Москва

https://orcid.org/0009-0009-7906-881XIsaevaM. T.ИсаеваМ. Т.
Russian Federation

123995; 2 / 1 Barricadnaya St.; Moscow

123995;  ул. Баррикадная 2 / 1; Москва

https://orcid.org/0000-0003-1341-0765PodvyaznikovS. O.ПодвязниковС. О.
Russian Federation

123995; 2 / 1 Barricadnaya St.; Moscow

123995;  ул. Баррикадная 2 / 1; Москва

N.N. Blokhin National Medical Russian Research Center of Oncology, Ministry of Health of RussiaФГБУ «Национальный медицинский исследовательский центр онкологии им. Н. Н. Блохина» Минздрава РоссииRussian Medical Academy of Continuing Professional Education, Ministry of Health of RussiaФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России301220231341161230704202407042024Copyright ©; 2023, Gelfand I.M., Kropotov M.A., Isaeva M.T., Podvyaznikov S.O.Copyright ©; 2023, Гельфанд И.М., Кропотов М.А., Исаева М.Т., Подвязников С.О.2023Gelfand I.M., Kropotov M.A., Isaeva M.T., Podvyaznikov S.O.Гельфанд И.М., Кропотов М.А., Исаева М.Т., Подвязников С.О.https://creativecommons.org/licenses/by/4.0https://ogsh.abvpress.ru/jour/article/view/943

   Skin cancer is the second most common tumor among non-melanoma malignant skin neoplasms, accounting for 20 % of cases. In the Russian federation in 2022, this pathology was identified in 79,124 people. The peak incidence occurs in the age range of 60–70 years. Considering the increasing life expectancy, the incidence of skin cancer is expected to rise. Despite the fact that regional metastases occur in 0.3–16 % of cases, the risk of metastasis can increase up to 48 % depending on high-risk factors. Since the presence of regional metastases is a key prognostic factor, special attention should be given to preventive interventions in the areas of regional metastasis.

   Рак кожи является второй по распространенности опухолью среди немеланомных злокачественных новообразований кожи и составляет 20 % случаев. В Российской Федерации в 2022 г. данная патология выявлена у 79 124 человек. Пик заболеваемости приходится на возраст 60–70 лет. С учетом роста продолжительности жизни заболеваемость раком кожи будет увеличиваться. Несмотря на то, что регионарные метастазы возникают в 0,3–16 % случаев, риск метастазирования может возрасти до 48 % в зависимости от факторов высокого риска. Поскольку наличие регионарных метастазов является основным прогностическим фактором, необходимо уделять особое внимание профилактическому воздействию на зоны регионарного метастазирования.

squamous cell carcinoma of the scalp and necksignal lymph nodesbiopsy of signal lymph noderegional metastasesплоскоклеточный рак кожи головы и шеисигнальные лимфатические узлыбиопсия сигнального лимфатического узларегионарные метастазыThe work was performed without external fundingРабота выполнена без спонсорской поддержкиLomas A., Leonardi-Bee J., Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012;166(5):1069–80. DOI: 10.1111/j.1365-2133.2012.10830.xLeiter U., Eigentler T., Garbe C. Epidemiology of skin cancer. Sunlight, vitamin D and skin cancer. NY: Springer, 2014. Pp. 120–140.The state of cancer care for the Russian population in 2022. Ed. by A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova. Moscow: P.A. Herzen Moscow State Medical Research Institute – branch of the Federal State Budgetary Institution “NMIC of Radiology” of the Ministry of Health of the Russian Federation, 2023. 250 p. (In Russ.).Состояние онкологической помощи населению России в 2022 году. Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2023. 250 с.Stratigos A., Garbe C., Lebbe C. et al. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline. Eur J Cancer 2015;51(14):1989–2007. DOI: 10.1016/j.ejca.2015.06.110Trakatelli M., Ulrich C., del Marmol V. et al. Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions. Br J Dermatol 2007;156(3):1–7. DOI: 10.1111/j.1365-2133.2007.07861.xAlbert A., Knoll M.A., Conti J.A., Zbar R.I.S. Non-melanoma skin cancers in the older patient. Curr Oncol Rep 2019;21(9):79. DOI: 10.1007/s11912-019-0828-9Stratigos A.J., Garbe C., Dessinioti C. et al. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin. Part 1. Epidemiology, diagnostics and prevention Eur J Cancer 2020;128:60–82. DOI: 10.1016/j.ejca.2020.01.007Gordon L.G., Rowell D. Health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening : a systematic review. Eur J Cancer Prev 2015;24(2):141–9. DOI: 10.1097/CEJ.0000000000000056Actinic keratosis: overview. Available at: http://www.skincarephysicians.com/actinickeratosesnet/whatAre.htm.Nguyen T.H., Ho D.Q. Nonmelanoma skin cancer. Curr Treat Options Oncol 2002;3(3):193–203. DOI: 10.1007/s11864-002-0009-0Armstrong B.K., Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B 2001;63(1–3):8–18. DOI: 10.1016/s1011-1344(01)00198-1Glass A.G., Hoover R.N. The emerging epidemic of melanoma and squamous cell skin cancer. JAMA 1989;262(15):2097–100.Veness M.J., Morgan G.J., Palme C.E., Gebski V. Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice. Laryngoscope 2005;115(5):870–5. DOI: 10.1097/01.MLG.0000158349.64337.EDRowe D.E., Carroll R.J., Day C.L. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. J Am Acad Dermatol 1992;26(6):976–90. DOI: 10.1016/0190-9622(92)70144-5Karia P.S., Han J., Schmults C.D. Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. J Am Acad Dermatol 2013;68(6):957–66. DOI: 10.1016/j.jaad.2012.11.037Mooney C.P., Martin R.C.W., Dirven R. et al. Sentinel node biopsy in 105 high-risk cutaneous SCCs of the head and neck: results of a multicenter prospective study. Ann Surg Oncol 2019;26(13):4481–8. DOI: 10.1245/s10434-019-07865-zLewis K.G., Weinstock M.A. Trends in nonmelanoma skin cancer mortality rates in the United States, 1969 through 2000. J Invest Dermatol 2007;127(10):2323–7. DOI: 10.1038/sj.jid.5700897Janković I., Kovačević P., Janković D. et al. Lymphatic drainage map of the head and neck skin squamous cell carcinoma detected by sentinel lymph node biopsy. Eur Rev Med Pharmacol Sci2021;25(16):5228–34. DOI: 10.26355/eurrev_202108_26536Veness M.J., Porceddu S., Palme C.E., Morgan G.J. Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head Neck 2007;29(7):621–31. DOI: 10.1002/hed.20576Veness M.J., Palme C.E., Morgan G.J. High-risk cutaneous squamous cell carcinoma of the head and neck. Cancer 2006;106(11):2389–96. DOI: 10.1002/cncr.21898Thompson A.K., Kelley B.F., Prokop L.J. et al. Risk factors for cutaneous squamous cell carcinoma recurrence, metastasis, and disease-specific death: a systematic review and meta-analysis. JAMA Dermatol 2016;152(4):419–28. DOI: 10.1001/jamadermatol.2015.4994Schmults C.D., Karia P.S., Carter J.B. et al. Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study. JAMA Dermatol 2013;149(5):541–7. DOI: 10.1001/jamadermatol.2013.2139O’Brien C.J., McNeil E.N., McMahon J.D. et al. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland. Head Neck 2002;24(5):417–22. DOI: 10.1002/hed.10063Ross A.S., Schmults C.D. Sentinel lymph node biopsy in cutaneous squamous cell carcinoma : a systematic review of the english literature. Dermatol Surg 2006;32(11):1309–21. DOI: 10.1111/j.1524-4725.2006.32300.xGallagher R.P., Hill G.B., Bajdik C.D. et al. Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma. Arch Dermatol 1995;131(2):157–63.Franceschi S., Levi F., Randimbison L., La Vecchia C. Site distribution of different types of skin cancer: new aetiological clues. Int J Cancer 1996;3(1):4–8. DOI: 10.1002/(SICI)1097-0215(19960703)67:1<24::AID-IJC6>3.0.CO;2-1Nouri K., Rivas M.P., Pedroso F. et al. Sentinel lymph node biopsy for high-risk cutaneous squamous cell carcinoma of the head and neck. Arch Dermatol 2004;140(10):1284. DOI: 10.1001/archderm.140.10.1284-aNuno-Gonzalez A., Vicente-Martin F.J., Pinedo-Moraleda F., Lopez-Estebaranz J.L. High-risk cutaneous squamous cell carcinoma. Actas Dermosifiliogr 2012;103:567–78. DOI: 10.1016/J.ADENGL.2012.08.004Navarrete-Dechent C., Veness M.J., Droppelmann N., Uribe P. Highrisk cutaneous squamous cell carcinoma and the emerging role of sentinel lymph node biopsy : a literature review. J Am Acad Dermatol 2015;73(1):127–37. DOI: 10.1016/j.jaad.2015.03.039Brantsch K.D., Meisner C., Schonfisch B. et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol 2008;9(8):713–20. DOI: 10.1016/S1470-2045(08)70178-5Veness M.J. Defining patients with high-risk cutaneous squamous cell carcinoma. Australas J Dermatol 2006;47(1):28–33. DOI: 10.1111/j.1440-0960.2006.00218.xEigentler T.K., Leiter U., Hafner H.M. et al. Survival of patients with cutaneous squamous cell carcinoma: results of a prospective cohort study. J Invest Dermatol 2017;137(11):2309–15. DOI: 10.1016/j.jid.2017.06.025Кaria P.S., Morgan F.C., Ruiz E.S., Schmults C.D. Clinical and incidental perineural invasion of cutaneous squamous cell carcinoma : а systematic review and pooled analysis of outcomes data. JAMA Dermatol 2017;153(8):781–8. DOI: 10.1001/jamadermatol.2017.1680Moore B.A., Weber R.S., Prieto V. et al. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck Lary ngoscope2005;115(9):1561–7. DOI: 10.1097/01.mlg.0000173202.56739.9fManyam B.V., Garsa A.A., Chin R.I. et al. A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck. Cancer 2017;123(11):2054–60. DOI: 10.1002/cncr.30601Oddone N., Morgan G.J., Palme C.E. et al. Metastatic cutaneous squamous cell carcinoma of the head and neck: the Immunosuppression, Treatment, Extranodal spread, and Margin status (ITEM) prognostic score to predict outcome and the need to improve survival. Cancer 2009;115(9):1883–91. DOI: 10.1002/cncr.24208Schmults C.D., Karia P.S., Carter J.B. et al. Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study. JAMA Dermatol 2013;149(5):541–7. DOI: 10.1001/jamadermatol.2013.2139Zavos G., Karidis N.P., Tsourouflis G., Bokos J. et al. Nonmelanoma skin cancer after renal transplantation: a single-center experience in 1736 transplantations. Int J Dermatol 2011;50(12):1496–500. DOI: 10.1111/j.1365-4632.2011.04939.xRenzi C., Caggiati A., Mannooranparampil T.J. et al. Sentinel lymph node biopsy for high risk cutaneous squamous cell carcinoma: case series and review of the literature. Eur J Surg Oncol 2007;33(3):364–9. DOI: 10.1016/j.ejso.2006.10.017Martorell-Calatayud A., Sanmartín Jimenez O., Cruz Mojarrieta J., Guillén Barona C. Cutaneous squamous cell carcinoma: defining the high-risk variant. Actas Dermosifiliogr 2013;104(5):367–79. DOI: 10.1016/j.adengl.2011.12.012Zwald F.O., Brown M. Skin cancer in solid organ transplant recipients: advances in therapy and management: part I. Epidemiology of skin cancer in solid organ transplant recipients. J Am Acad Dermatol 2011;65(2):253–61. DOI: 10.1016/j.jaad.2010.11.062Kwon S., Dong Z.M., Wu P.C. Sentinel lymph node biopsy for highrisk cutaneous squamous cell carcinoma : clinical experience and review of literature. World J Surg Oncol 2011;9:80. DOI: 10.1186/1477-7819-9-80American Joint Committee on Cancer. Cutaneous squamous cell carcinoma and other cutaneous carcinomas. 7th ed. NY: Springer, 2010.Stoff B., Salisbury C., Parker D., O’Reilly Zwald F. Dermatopathology of skin cancer in solid organ transplant recipients. Transplant Rev (Orlando) 2010:24(4):172–89. DOI: 10.1016/j.trre.2010.05.002Brougham N.D., Tan S.T. The incidence and risk factors of metastasis for cutaneous squamous cell carcinoma – implications on the T-classification system. J Surg Oncol 2014;110(7):876–82. DOI: 10.1002/jso.23731Tomaszewski J.M., Gavriel H., Link E. et al. Aggressive behavior of cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia. Laryngoscope 2014;124(9):2043–8. DOI: 10.1002/lary.24586Martinez J.C., Otley C.C., Stasko T. et al. Defining the clinical course of metastatic skin cancer in organ transplant recipients: a mul ticenter collaborative study. Arch Dermatol 2003;139(3): 301–6. DOI: 10.1001/archderm.139.3.301Friedman N.R. Prognostic factors for local recurrence, metastases, and survival rates in squamous cell carcinoma of the skin, ear, and lip. J Am Acad Dermatol 1993;28(2 Pt. 1):281–2. DOI: 10.1016/s0190-9622(08)81164-4Peat B., Insull P., Ayers R. Risk stratification for metastasis from cutaneous squamous cell carcinoma of the head and neck. ANZ J Surg 2012;82(4):230–3. DOI: 10.1111/j.1445-2197.2011.05994.xShen R., Zhang J., Zhang F. et al. Clinical characteristics and therapeutic analysis of 51 patients with Marjolin’s ulcers. Exp Ther Med 2015;10(4):1364–74. DOI: 10.3892/etm.2015.2699Breuninger H., Schaumburg-Lever G., Holzschuh J., Horny H.P. Desmoplastic squamous cell carcinoma of skin and vermilion surface: a highly malignant subtype of skin cancer. Cancer 1997;79(5):915–9. DOI: 10.1002/(sici)1097-0142(19970301)79:5<915::aid-cncr7>3.0.co;2-aGarcia-Pedrero J.M., Martinez-Camblor P., Diaz-Coto S. et al. Tumor programmed cell death ligand 1 expression correlates with nodal metastasis in patients with cutaneous squamous cell carcinoma of the head and neck. J Am Acad Dermatol 2017;77(3):527–33. DOI: 10.1016/j.jaad.2017.05.047Wong W.K., Morton R.P. Elective management of cervical and parotid lymph nodes in stage N0 cutaneous squamous cell carcinoma of the head and neck: a decision analysis. Eur Arch Otorhinolaryngol 2014;271(11):3011–9. DOI: 10.1007/s00405-013-2857-6Skulsky S.L., O’Sullivan B., McArdle O. et al. Review of high-risk features of cutaneous squamous cell carcinoma and discrepancies between the American Joint Committee on Cancer and NCCN Clinical Practice Guidelines In Oncology. Head Neck 2017;39(3):578–94. DOI: 10.1002/hed.24580Kadakia S., Saman M., Gordin E. et al. The role of parotidectomy in the treatment of auricular squamous cell carcinoma. Otolaryngol Head Neck Surg 2015;152(6):1048–52. DOI: 10.1177/0194599815579885Martinez J.C., Cook J.L. High-risk cutaneous squamous cell carcinoma without palpable lymphadenopathy: is there a therapeutic role for elective neck dissection? Dermatol Surg 2007;33(4):410–20. DOI: 10.1111/j.1524-4725.2007.33087.xAmit M., Liu C., Mansour J. et al. Elective neck dissection versus observation in patients with head and neck cutaneous squamous cell carcinoma. Cancer 2021;127(23):4413–20. DOI: 10.1002/cncr.33773Staples M.P., Elwood M., Burton R.C. et al. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust 2006;184(1):6–10. DOI: 10.5694/j.1326-5377.2006.tb00086.xFukushima S., Masuguchi S., Igata T. et al. Evaluation of sentinel node biopsy for cutaneous squamous cell carcinoma. J Dermatol 2014;41(6):539–41. DOI: 10.1111/1346-8138.12508Forest V.I., Clark J.J., Veness M.J., Milross C. N1S3: a revised staging system for head and neck cutaneous squamous cell carcinoma with lymph node metastases: results of 2 Australian Cancer Centers. Cancer 2010;116(5):1298–304. DOI: 10.1002/cncr.24855Allen J.E., Stolle L.B. Utility of sentinel node biopsy in patients with high-risk cutaneous squamous cell carcinoma. Eur J Surg Oncol 2015;41(2):197–200. DOI: 10.1016/j.ejso.2014.10.055Ahadiat O., Higgins S., Sutton A. et al. SLNB in cutaneous SCC : A review of the current state of literature and the direction for the future. J Surg Oncol 2017;116:344–50.Gore S.M., Shaw D., Martin R.C. et al. Prospective study of sentinel node biopsy for high-risk cutaneous squamous cell carcinoma of the head and neck. Head Neck 2016;38(Suppl. 1): E884–9. DOI: 10.1002/hed.24120Navarrete-Dechent C., Veness M.J., Droppelmann N., Uribe P. Cutaneous squamous cell carcinoma and the emerging role of sentinel lymph node biopsy. G Ital Dermatol Venereol 2018;153(3):403–18. DOI: 10.23736/S0392-0488.18.05936-9Lubov J., Labbé M., Sioufi K. et al. Prognostic factors of head and neck cutaneous squamous cell carcinoma : a systematic review. J Otolaryngol Head Neck Surg 2021;50(1):54. DOI: 10.1186/s40463-021-00529-7Durham A.B., Lowe L., Malloy K.M. et al. Sentinel lymph node biopsy for cutaneous squamous cell carcinoma on the head and neck. JAMA Otolaryngol Head Neck Surg 2016;142(12):1171–6. DOI: 10.1001/jamaoto.2016.1927Schmults C.D. NCCN Clinical Practice Guidelines in Oncology. Squamous cell skin cancer, version 1.2022 J Natl Compr Canc Netw 2021;19(12):1382–94. DOI: 10.6004/jnccn.2021.0059Haisma M.S., Plaat B.E C., Bijl H.P. et al. Multivariate analysis of potential risk factors for lymph node metastasis in patients with cutaneous squamous cell carcinoma of the head and neck. J Am Acad Dermatol 2016;75(4):722–30. DOI: 10.1016/j.jaad.2016.06.010Yesensky J. Sentinel lymph node biopsy for cutaneous squamous cell carcinoma of the head and neck. 2023. Available at: https://clinicaltrials.gov/study/NCT05108090.